Market Cap 2.97B
Revenue (ttm) 1.82B
Net Income (ttm) -845.00M
EPS (ttm) N/A
PE Ratio 18.76
Forward PE 16.50
Profit Margin -46.33%
Debt to Equity Ratio 0.74
Volume 746,800
Avg Vol 724,710
Day's Range N/A - N/A
Shares Out 45.76M
Stochastic %K 99%
Beta 0.43
Analysts Strong Sell
Price Target $68.18

Company Profile

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricu...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 302 995 3000
Address:
8145 Blazer Drive, Wilmington, United States
SuperGreenToday
SuperGreenToday Feb. 18 at 2:53 PM
$ASH Share Price: $60.99 Contract Selected: Jul 17, 2026 $60 Calls Buy Zone: $5.65 – $6.97 Target Zone: $9.22 – $11.27 Potential Upside: 54% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
erevnon
erevnon Feb. 18 at 2:51 PM
Evercore ISI Group maintains Ashland $ASH at In-Line and raises the price target from $53 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Broview
Broview Feb. 14 at 8:20 AM
$ASH cautiously adding?
0 · Reply
ZacksResearch
ZacksResearch Feb. 10 at 5:24 PM
$ASH just cleared a major regulatory hurdle — and the market may be underpricing it 👀 Ashland’s agrimer eco-coat polymer seed coating just won U.S. EPA approval, expanding market access and enabling use across both food and non-food pesticide formulations — a meaningful unlock for adoption. What this approval could mean for Ashland’s growth story 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-teaser-32858&ADID=SYND_STOCKTWITS_TWEET_2_2847694_TEASER_32858
0 · Reply
ZacksResearch
ZacksResearch Feb. 10 at 4:24 PM
$ASH gets EPA approval for new seed coating — time to watch this space! 🌱 Their agrimer eco-coat polymer, built on patented TVO technology, is now cleared for use in food and non-food pesticide formulations, boosting its market reach and sustainability impact. See why this innovation could drive growth for Ashland 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-body-32856&ADID=SYND_STOCKTWITS_TWEET_2_2847694_BODY_32856
0 · Reply
twib
twib Feb. 9 at 10:32 AM
0 · Reply
WoodardWaves
WoodardWaves Feb. 4 at 9:38 AM
$ASH specialty chemicals, performance materials
0 · Reply
Estimize
Estimize Feb. 3 at 1:42 PM
$ASH reported 0.26 EPS and 386.00 revenue for Q1. http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_content=ASH&utm_me
0 · Reply
ZacksResearch
ZacksResearch Feb. 3 at 12:06 PM
$ASH just beat earnings — but the top line tells a different story. ⚠️ Ashland’s Q1 2026 loss narrowed year over year and topped estimates, while sales fell 5% as the Avoca divestiture and weaker end-market demand weighed on results. Is this earnings beat enough to offset the revenue pressure? Full breakdown here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-teaser-31587&ADID=SYND_STOCKTWITS_TWEET_2_2827565_TEASER_31587
0 · Reply
ZacksResearch
ZacksResearch Feb. 3 at 11:06 AM
$ASH Q1: A mixed bag with a beat on earnings but a miss on sales 📉 🔹 Adjusted EPS of 26 cents topped estimates, despite a dip from last year. 🔹 Sales down 5% year over year, missing consensus due to divestitures and softer demand in key markets. 🔹 Life Sciences shines with 4% sales growth, but Personal Care and Specialty Additives lag behind. See the full breakdown of Ashland’s performance here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-body-31586&ADID=SYND_STOCKTWITS_TWEET_2_2827565_BODY_31586
0 · Reply
Latest News on ASH
Ashland Inc. (ASH) Q1 2026 Earnings Call Transcript

Feb 3, 2026, 1:30 PM EST - 19 days ago

Ashland Inc. (ASH) Q1 2026 Earnings Call Transcript


Ashland board authorizes quarterly dividend

Jan 19, 2026, 5:01 PM EST - 4 weeks ago

Ashland board authorizes quarterly dividend


Top 2 Materials Stocks That May Fall Off A Cliff This Quarter

Dec 5, 2025, 12:29 PM EST - 2 months ago

Top 2 Materials Stocks That May Fall Off A Cliff This Quarter

NUE


Ashland Inc. (ASH) Q4 2025 Earnings Call Transcript

Nov 5, 2025, 4:11 PM EST - 3 months ago

Ashland Inc. (ASH) Q4 2025 Earnings Call Transcript


Ashland announces Sandy Klugman, director, investor relations

Oct 14, 2025, 5:01 PM EDT - 4 months ago

Ashland announces Sandy Klugman, director, investor relations


Ashland Inc. (ASH) Q3 2025 Earnings Call Transcript

Jul 30, 2025, 2:01 PM EDT - 7 months ago

Ashland Inc. (ASH) Q3 2025 Earnings Call Transcript


Operations leadership changes announced at Ashland

Jul 14, 2025, 5:00 PM EDT - 7 months ago

Operations leadership changes announced at Ashland


Ashland advances strategic $60MM network optimization

Jul 8, 2025, 5:00 PM EDT - 8 months ago

Ashland advances strategic $60MM network optimization


Ashland hosts Innovation Day for analysts and investors

May 28, 2025, 5:00 PM EDT - 9 months ago

Ashland hosts Innovation Day for analysts and investors


Ashland announces executive leadership changes

May 5, 2025, 5:00 PM EDT - 10 months ago

Ashland announces executive leadership changes


Ashland, Inc. (ASH) Q2 2025 Earnings Call Transcript

May 1, 2025, 7:48 PM EDT - 10 months ago

Ashland, Inc. (ASH) Q2 2025 Earnings Call Transcript


Ashland to host 2025 Innovation Day for analysts and investors

Mar 28, 2025, 6:59 AM EDT - 11 months ago

Ashland to host 2025 Innovation Day for analysts and investors


Ashland completes sale of Avoca business to Mane

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Ashland completes sale of Avoca business to Mane


The Best Materials Stocks to Buy

Feb 10, 2025, 12:53 PM EST - 1 year ago

The Best Materials Stocks to Buy

AVY BALL DD FMC GPK PKG RPM


Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript

Jan 29, 2025, 9:24 PM EST - 1 year ago

Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript


Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript

Nov 9, 2024, 4:16 PM EST - 1 year ago

Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript


Ashland completes sale of nutraceuticals business

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Ashland completes sale of nutraceuticals business


Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript

Aug 7, 2024, 6:27 PM EDT - 1 year ago

Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript


SuperGreenToday
SuperGreenToday Feb. 18 at 2:53 PM
$ASH Share Price: $60.99 Contract Selected: Jul 17, 2026 $60 Calls Buy Zone: $5.65 – $6.97 Target Zone: $9.22 – $11.27 Potential Upside: 54% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
erevnon
erevnon Feb. 18 at 2:51 PM
Evercore ISI Group maintains Ashland $ASH at In-Line and raises the price target from $53 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Broview
Broview Feb. 14 at 8:20 AM
$ASH cautiously adding?
0 · Reply
ZacksResearch
ZacksResearch Feb. 10 at 5:24 PM
$ASH just cleared a major regulatory hurdle — and the market may be underpricing it 👀 Ashland’s agrimer eco-coat polymer seed coating just won U.S. EPA approval, expanding market access and enabling use across both food and non-food pesticide formulations — a meaningful unlock for adoption. What this approval could mean for Ashland’s growth story 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-teaser-32858&ADID=SYND_STOCKTWITS_TWEET_2_2847694_TEASER_32858
0 · Reply
ZacksResearch
ZacksResearch Feb. 10 at 4:24 PM
$ASH gets EPA approval for new seed coating — time to watch this space! 🌱 Their agrimer eco-coat polymer, built on patented TVO technology, is now cleared for use in food and non-food pesticide formulations, boosting its market reach and sustainability impact. See why this innovation could drive growth for Ashland 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-body-32856&ADID=SYND_STOCKTWITS_TWEET_2_2847694_BODY_32856
0 · Reply
twib
twib Feb. 9 at 10:32 AM
0 · Reply
WoodardWaves
WoodardWaves Feb. 4 at 9:38 AM
$ASH specialty chemicals, performance materials
0 · Reply
Estimize
Estimize Feb. 3 at 1:42 PM
$ASH reported 0.26 EPS and 386.00 revenue for Q1. http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_content=ASH&utm_me
0 · Reply
ZacksResearch
ZacksResearch Feb. 3 at 12:06 PM
$ASH just beat earnings — but the top line tells a different story. ⚠️ Ashland’s Q1 2026 loss narrowed year over year and topped estimates, while sales fell 5% as the Avoca divestiture and weaker end-market demand weighed on results. Is this earnings beat enough to offset the revenue pressure? Full breakdown here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-teaser-31587&ADID=SYND_STOCKTWITS_TWEET_2_2827565_TEASER_31587
0 · Reply
ZacksResearch
ZacksResearch Feb. 3 at 11:06 AM
$ASH Q1: A mixed bag with a beat on earnings but a miss on sales 📉 🔹 Adjusted EPS of 26 cents topped estimates, despite a dip from last year. 🔹 Sales down 5% year over year, missing consensus due to divestitures and softer demand in key markets. 🔹 Life Sciences shines with 4% sales growth, but Personal Care and Specialty Additives lag behind. See the full breakdown of Ashland’s performance here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-body-31586&ADID=SYND_STOCKTWITS_TWEET_2_2827565_BODY_31586
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 2 at 10:20 PM
$ASH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.26 up 92.59% YoY • Reported revenue of $386M down -4.69% YoY • Ashland narrowed its full-year fiscal 2026 Adjusted EBITDA guidance to $400-$420 million, reflecting $11 million of temporary impacts. Sales are projected to be $1,835 million to $1,905 million, supported by innovation-driven product lines.
0 · Reply
Estimize
Estimize Feb. 2 at 4:00 PM
$ASH reports after the close, Estimize Consensus +0.02 EPS and +0.25M Revs compared to WS http://www.estimize.com/ash/fq1-2026?utm_content=
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 27 at 1:10 AM
$ASH Current Stock Price: $62.47 Contracts to trade: $60 ASH Feb 20 2026 Call Entry: $3.60 Exit: $5.01 ROI: 39% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 5:01 PM
$ASH RSI: 70.31, MACD: 1.8205 Vol: 1.63, MA20: 60.16, MA50: 55.72 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
IN0V8
IN0V8 Jan. 12 at 6:24 PM
$ASH UBS raises target price to $70 from $64 Argus Research raises target price to $70 from $65
0 · Reply
twib
twib Jan. 10 at 12:45 AM
0 · Reply
twib
twib Jan. 7 at 3:20 PM
$ASH Nice little hop off lows!
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 23 at 3:49 PM
$ASH Current Stock Price: $58.91 Contracts to trade: $60 ASH Jan 16 2026 Call Entry: $0.45 Exit: $0.57 ROI: 27% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 2:33 PM
Wells Fargo updates rating for Ashland ( $ASH ) to Equal-Weight, target set at 51 → 60.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 1:19 PM
Mizuho has adjusted their stance on Ashland ( $ASH ), setting the rating to Outperform with a target price of 60 → 70.
0 · Reply
Estimize
Estimize Dec. 17 at 1:03 PM
Wall St is expecting 0.24 EPS for $ASH Q1 [Reporting 02/03 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont
0 · Reply
RunnerSignals
RunnerSignals Dec. 15 at 8:22 PM
$ASH $CRL $CVX stock upgrades today with near-term gains possible https://stocksrunner.com/news/2025-12-15-stock-upgrades-today-show-top-picks
0 · Reply